Literature DB >> 7990704

The role of glucagon in the control of protein and amino acid metabolism in vivo.

P J Flakoll1, M J Borel, L S Wentzel, P E Williams, D B Lacy, N N Abumrad.   

Abstract

The relative contribution of hyperglucagonemia to the mechanisms of nitrogen loss during catabolic states has not been clearly established. The present study examines the independent effect of physiologic elevations of plasma glucagon on whole-body protein kinetics, as well as on net amino acid balance across the liver and gastrointestinal tract tissues, in conscious 18-hour-fasted dogs (n = 7). Each study consisted of a 120-minute equilibration period, a 30-minute basal period, and a 150-minute experimental period. Leucine kinetics were measured using L-[1-14C]leucine. Pancreatic hormones were maintained by infusing intravenous somatostatin (0.8 micrograms/kg.min), intraportal insulin (275 microU/kg.min), and intraportal glucagon (0.65 ng/kg.min basally and 2.5 experimentally). Dextrose was infused to maintain plasma glucose constant (14.1 +/- 0.3 mumol/L), thereby providing a consistent metabolic steady state for the study of protein and amino acid metabolism. In the experimental period, plasma glucagon was fourfold basal levels (112 +/- 10 v 32 +/- 6 pg/mL), whereas plasma insulin remained stable (mean, 10 +/- 1 microU/mL). Hepatic glucose production was increased 30%, but leucine rates of appearance ([Ra] proteolysis), oxidative disappearance (Rd), and nonoxidative Rd (protein synthesis) were not altered during the experimental period. Furthermore, the net release of amino acids by the gastrointestinal tract was not increased by glucagon. However, uptake and extraction of amino acids by the liver were increased, resulting in a 17% decrease in total plasma amino acids.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7990704     DOI: 10.1016/0026-0495(94)90009-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Evidence for a catabolic role of glucagon during an amino acid load.

Authors:  M R Charlton; D B Adey; K S Nair
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Glucagon's effect on liver protein metabolism in vivo.

Authors:  Guillaume Kraft; Katie C Coate; Jason J Winnick; Dominique Dardevet; E Patrick Donahue; Alan D Cherrington; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-23       Impact factor: 4.310

3.  The kinetics of glucagon action on the liver during insulin-induced hypoglycemia.

Authors:  Christina Pedersen; Guillaume Kraft; Dale S Edgerton; Melanie Scott; Ben Farmer; Marta Smith; David C Laneve; Phillip E Williams; L Merkle Moore; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-03-24       Impact factor: 4.310

Review 4.  Glucagon: acute actions on hepatic metabolism.

Authors:  Russell A Miller; Morris J Birnbaum
Journal:  Diabetologia       Date:  2016-04-26       Impact factor: 10.122

5.  Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.

Authors:  Katrine D Galsgaard; Marie Winther-Sørensen; Cathrine Ørskov; Hannelouise Kissow; Steen S Poulsen; Hendrik Vilstrup; Cornelia Prehn; Jerzy Adamski; Sara L Jepsen; Bolette Hartmann; Jenna Hunt; Maureen J Charron; Jens Pedersen; Nicolai J Wewer Albrechtsen; Jens J Holst
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-03       Impact factor: 4.310

6.  Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis.

Authors:  Qiaofeng Liu; Guangyao Lin; Yan Chen; Wenbo Feng; Yingna Xu; Jianjun Lyu; Dehua Yang; Ming-Wei Wang
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

7.  Repeated post-exercise administration with a mixture of leucine and glucose alters the plasma amino acid profile in Standardbred trotters.

Authors:  Katarina E A Nostell; Birgitta Essén-Gustavsson; Johan T Bröjer
Journal:  Acta Vet Scand       Date:  2012-02-01       Impact factor: 1.695

8.  Late gestation fetal hyperglucagonaemia impairs placental function and results in diminished fetal protein accretion and decreased fetal growth.

Authors:  Sarah N Cilvik; Stephanie R Wesolowski; Russ V Anthony; Laura D Brown; Paul J Rozance
Journal:  J Physiol       Date:  2021-05-10       Impact factor: 6.228

9.  Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist.

Authors:  James Mu; Sajjad A Qureshi; Edward J Brady; Eric S Muise; Mari Rios Candelore; Guoqiang Jiang; Zhihua Li; Margaret S Wu; Xiaodong Yang; Qing Dallas-Yang; Corey Miller; Yusheng Xiong; Ronald B Langdon; Emma R Parmee; Bei B Zhang
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

Review 10.  Problem or solution: The strange story of glucagon.

Authors:  R V Scott; S R Bloom
Journal:  Peptides       Date:  2018-02       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.